NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
July 25, 2006 • Volume 3 / Number 30 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Study Strengthens Argument of Cancer as "Wounds that Do Not Heal"

Director's Update
Disparities Summit Offers Real Answers to Real Problems

Spotlight
Sharing Strategies to Navigate the Drug Development Pathway

Cancer Research Highlights
HPV Co-Infections May Increase Risk of Precancerous Lesions

Test for Bladder Cancer Analyzes DNA in Urine

Tissue Growth Factor Inhibits Metastatic Activity in Lung Cancer

Smoking Blamed for Half of Difference in Death Rates

SPORE Investigators' Workshop Held July 16-19

Funding Opportunities

Featured Clinical Trial
Adjuvant Bisphosphonates for Breast Cancer

Notes
Dr. Tsuyoshi Kakefuda
Dies at 77


NIH Roadmap Featured

NCI Symposium Celebrates Progress in Cytogenetics

Call for Posters Deadline Extended

AIDS Malignancy Program Conference Scheduled for October

A Conversation with
Dr. Kim Lyerly


Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Funding Opportunities Funding Opportunities

Featured Meetings and Events
A calendar of scientific meetings and events sponsored by the National Institutes of Health (NIH) is available at http://calendar.nih.gov.
Following are newly released NCI research funding opportunities:

Mechanisms of Immune Modulation
Announcement Number: RFA-AT-06-005
Application Receipt Date: Dec. 12, 2006

This funding opportunity will use the R21 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3507. Inquiries: Dr. Young S. Kim - yk47s@nih.gov

Assay Development for High Throughput Molecular Screening
Announcement Number: RFA-RM-07-001
Letter of Intent Receipt Date: Sept. 8, 2006
Application Receipt Date: Sept. 22, 2006

This is a renewal of RFA-RM-06-004 and will use the R21 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3508. Inquiries: Dr. Mark Scheideler - scheidelerm@ninds.nih.gov

For comprehensive information about NCI funding priorities and opportunities, go to http://www.cancer.gov/researchfunding.

The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. For information on additional Roadmap funding opportunities, go to http://nihroadmap.nih.gov.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov